2-METHYLPROPYLZINC BROMIDE
Product Information
Molecular Formula
C4H9BrZn
Molecular Weight
202.41
Description
2-METHYLPROPYLZINC BROMIDE is a crucial reagent widely used in the biomedical industry. It serves as an effective precursor in the synthesis of various organic compounds, particularly pharmaceutical drugs. This chemical compound is utilized in the production of novel therapies for the treatment of multiple diseases, including cancer, infectious diseases, and neurological disorders.
Synonyms
ISOBUTYLZINC BROMIDE; 2-METHYLPROPYLZINC BROMIDE; ISOBUTYLZINC BROMIDE, 0.5M SOLUTION IN T ETRAHYDROFURAN; isobutylzinc bromide solution
IUPAC Name
bromozinc(1+)2-methanidylpropane
SMILES
CC(C)[CH2-].[Zn+]Br
InChI
InChI=1S/C4H9.BrH.Zn/c1-4(2)3/h4H,1H2,2-3H31H/q-1+2/p-1
InChI Key
DSDCDMKASWVZHI-UHFFFAOYSA-M
Flash Point
1.4 °F - closed cup
Density
0.943 g/mL at 25 °C
Appearance
brown to black liquid
Storage
2-8°C
Safety Information
Hazards
H225 - H261 - H302 - H315 - H319 - H335 - H351
Precautionary Statement
P210 - P231 + P232 - P280 - P370 + P378 - P402 + P404 - P403 + P235
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Rotatable Bond Count
0
Exact Mass
199.91790 g/mol
Monoisotopic Mass
199.91790 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
6
Formal Charge
0
Complexity
15
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2011071126-A1 | Inhibitors of beta-secretase | 2009-03-13 |
| US-2010160369-A1 | S1P1 Agonists and Methods of Making And Using | 2008-12-04 |
| US-2010041658-A1 | Hydroxyphenyl Derivatives and Biological Applications Thereof | 2006-04-14 |
| US-2007244169-A1 | Glucokinase activators | 2005-12-20 |
| US-2007135631-A1 | Heterocyclic cetp inhibitors | 2005-11-23 |
| US-2010267669-A1 | Heterocyclic cetp inhibitors | 2005-11-23 |
| US-7790770-B2 | Heterocyclic CETP inhibitors | 2005-11-23 |
| US-2005267199-A1 | 2-Amino- and 2-thio- substituted 1,3-diaminopropanes | 2004-03-25 |
| US-7544717-B2 | 2-amino- and 2-thio- substituted 1,3-diaminopropanes | 2004-03-25 |
| US-2005239832-A1 | Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors | 2004-03-09 |
